心理学辅助疗法:内科医生的概述
Brian S Barnett1, Erin E Mauney2, Franklin King3
1Department of Psychiatry and Psychology, Cleveland Clinic, Cleveland, OH; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH; Principal investigator, Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD NCT05711940, and A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (VOYAGE) NCT06741228 barnetb3@ccf.org.
迷幻药辅助疗法在治疗抑郁症和创伤后应激障碍等精神健康状况方面表现有前景. 然而,最近的监管决定强调了这些新型治疗方法的不断变化的景观.
科学领域:
- 精神病学和神经科学 精神病学和神经科学
- 药理学 药理学是指药理学的学科.
- 临床心理学 临床心理学
背景情况:
- 初步证据表明,使用诸如3,4-甲基二氧化甲胺 (MDMA) 和 псилоцибин等物质的幻觉辅助疗法,可以有效治疗抑郁症,PTSD和物质使用障碍.
- 治疗性迷幻药物的研究正在取得进展,其中关键化合物如psilocybin,MDMA和lysergic acid diethylamide被FDA认可为突破性的疗法.
研究的目的:
- 为了总结目前的幻觉辅助疗法研究的现状.
- 告知临床医生关于心理药物在医疗实践中的潜在整合.
主要方法:
- 审查初步证据和最近的监管发展在迷幻研究.
- 分析FDA关于迷幻疗法的指标和决定.
主要成果:
- 迷幻药辅助疗法在几个心理健康状况中显示出潜在的有效性.
- 尽管有突破性的治疗指标,但最近对MDMA的新药申请被拒绝,需要进一步的试验.
结论:
- 迷幻医学领域正在进步,但监管途径仍然复杂.
- 临床医生应该为未来的潜在可用性和将迷幻药辅助疗法纳入临床实践做好准备.
更多相关视频
08:20Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
Published on: January 18, 2021
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
相关概念视频
CNS Stimulants: Psychedelic Agents
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Drug Therapy
Antianxiety Medications
Interpersonal Psychotherapy
An Overview of Psychoactive Drugs
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Group Therapy
